Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ VRNS Investor Alert: Hagens Berman Scrutinizing Varonis Systems (VRNS) Amid Claims of Alleged SaaS... (PR Newswire) +++ VARONIS Aktie -3,70%

Foren & Soziale Netzwerke zur HIMS & HERS Aktie

 >HIMS & HERS Aktienkurs 
20.78 EUR    -3.9%    (Tradegate)
Ask: 20.78 EUR / 2600 Stück
Bid: 20.71 EUR / 2600 Stück
Tagesumsatz: 37430 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
HIMS & HERS Aktie über LYNX handeln
>HIMS & HERS Performance
1 Woche: -10,8%
1 Monat: -24,7%
3 Monate: -44,2%
6 Monate: -59,9%
1 Jahr: -42,8%
laufendes Jahr: -25,6%
>HIMS & HERS Aktie
Name:  HIMS & HERS HEALTH INC.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US4330001060 / A2QMYY
Symbol/ Ticker:  82W (Frankfurt) / HIMS (NYSE)
Kürzel:  FRA:82W, ETR:82W, 82W:GR, NYSE:HIMS
Index:  -
Webseite:  https://www.hims.com/
Profil:  Hims & Hers Health, Inc. is a telehealth service p..
>Volltext..
Marktkapitalisierung:  5095.11 Mio. EUR
Unternehmenswert:  5510.34 Mio. EUR
Umsatz:  1871.58 Mio. EUR
EBITDA:  147.53 Mio. EUR
Nettogewinn:  113.25 Mio. EUR
Gewinn je Aktie:  0.51 EUR
Schulden:  946.41 Mio. EUR
Liquide Mittel:  292.7 Mio. EUR
Operativer Cashflow:  272.31 Mio. EUR
Bargeldquote:  1.4
Umsatzwachstum:  68.91%
Gewinnwachstum:  25.37%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 581.567 USD.
Suchwörter:  HIMS & HERS, HIMS AND HERS, HIMS HERS
Letzte Datenerhebung:  04.02.26
>HIMS & HERS Kennzahlen
Aktien/ Unternehmen:
Aktien: 219.27 Mio. St.
Frei handelbar: 94.27%
Rückkaufquote: -0.15%
Mitarbeiter: 1637
Umsatz/Mitarb.: 0.76 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 66.3%
Bewertung:
KGV: 46.38
KGV lG: 53.22
KUV: 2.97
KBV: 9.82
PEG-Ratio: 1.94
EV/EBITDA: 37.35
Rentabilität:
Bruttomarge: 65.4%
Gewinnmarge: 6.05%
Operative Marge: 5.96%
Managementeffizenz:
Gesamtkaprendite: 9.44%
Eigenkaprendite: 26.21%
>HIMS & HERS Peer Group
Gesundheit, Nahrungsergänzungsmittel & Wellnessprodukte, Kosmetik, Körperpflege & Parfüms
 
09.01.26 - 13:03
HIMS: on the accumulation zone (TradingView)
 
NYSE:HIMS : . On the accumulation zone Demand zone support. Less supply volume at the bottom. HIMS is swinging on range, wait for Smart money been confirmed with Engulfing candle and volume together. . US STOCKS- WALL STREET DREAM- LET'S THE MARKET SPEAK!
31.12.25 - 16:51
$HIMS - RSI+MACD Divergences for Bullish Plays (TradingView)
 
I think that NYSE:HIMS has an upside potential considering there are clear positive divergences in RSI and MACD. These have also been highlighted at various instances in the past where the price rocketed upwards after giving divergences in RSI and MACD; the price, at that point, either consolidated or gave a rough double bottom. Furthermore, the shrinking volumes add some fuel to fire. I think that the upside potential is up to $47 which I have calculated by using an AVWAP (anchored at its all-time high). This also sort of makes this a mean-reversion trade. So, fingers crossed! Hope to see it up now; otherwise, it'll probably fall to $25 which happens to be an extreme low given after making the all-time high.
31.12.25 - 16:39
$HIMS - RSI+MACD Divergences for Bullish Play (TradingView)
 
I think that NYSE:HIMS has an upside potential considering there are clear positive divergences in RSI and MACD. These have also been highlighted at various instances in the past where the price rocketed upwards after giving divergences in RSI and MACD; the price, at that point, either consolidated or gave a rough double bottom. So, fingers crossed! Hope to see it up now; otherwise, it'll fall to $25 and we'll see where it goes.
31.12.25 - 15:42
12/31/25 - $hims - a bite (TradingView)
 
12/31/25 :: VROCKSTAR :: NYSE:HIMS a bite - growing 20% a year - AI winner disty channel for repeat customer/ consumption type - founder led, n=1 type - sub 30x pe - cash generative (even if low SD fcf yields) - LT winner - buy V
09.12.25 - 02:45
HIMS - reversal trade (TradingView)
 
This is a setup on HIMS I'm going to play with the right volume.
23.11.25 - 02:51
HIMS: timing to buy the dip! (TradingView)
 
HIMS: Timing to buy the dip! Wait for more drop, for an optimal plan. US STOCKS- WALL STREET DREAM- LET'S THE MARKET SPEAK!
14.11.25 - 00:27
$HIMS growth is moderating starting 2025 (TradingView)
 
- NYSE:HIMS had explosive growth in 2025 but it will grow only 20% yoy going forward. - Their eps really sucks and will moderate as well. There is no point in giving a multiple more than 30. Fair value : year : 2025 , eps: 0.48 , fair value: 30 x 0.48 =~ $15 year : 2027 , eps: 0.68 , fair value: 30 x 0.68 =~ $21 year : 2028 , eps: 0.88 , fair value: 30 x 0.88 =~ $27
04.11.25 - 15:03
Bank_of_America_Co_: sell Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 27.8048 €
28.10.25 - 15:03
Put sale on HIMS over earnings (TradingView)
 
I like HIMS and OSCR A LOT in this market and environment right now. :) So, getting HIMS at $38 seems like a gift. JUST closed .80 gain on a put sale. So cost basis would be a tad lower than $37 if I get put shares...
23.10.25 - 02:03
HIMS to $76 (TradingView)
 
HIMS is incredibly profitable and also a highly shorted stock (33%). It might tap support here, but if not just below the trend line seems like a nice entry. Good luck!
17.10.25 - 17:15
HIMS put sale (TradingView)
 
THIS HAS BEEN such a fun stock to trade. BIG DOWN DAY. This put sale is before earnings. AMAZING premiums. Puts the cost basis at $44. GORGEOUS
04.10.25 - 19:27
$HIMS growth slowdown ahead (TradingView)
 
- NYSE:HIMS is quite overvalued. There's no moat to a business model. - They got a good branding that's all. There are 10-15 other startups selling the same things under different umbrella. - They even stole NYSE:NVO flagship weight loss drugs. These cheap alternatives will risk lives of people and will open plethora of lawsuits. - Growth is slowing down to low 20s which calls for correction in the multiple. - Anyone paying more than 20x will likely suffer from massive losses within an year timeframe. - Fundamentally, Year | 2025 | 2026 | 2027 | 2028 EPS | 0.57 | 0.79 | 1.05 | 1.40 EPS% | 5.76% | 38.31% | 32.59% | 33.25% Giving benefit of doubt and being generous, 30x multiple as a base case. Fair stock value: Year | 2025 | 2026 | 2027 | 2028 Price | $17 | $23 | $31 | $42 - We should visit the $23-26 range somewhere in 2026
18.09.25 - 20:33
HIMS Long target 73 $ (TradingView)
 
After retesting 3 times a fib fan resistence, i think it will break very strong this time and it will bounce much higher. Then, on weekly timeframe, it seems a nice cup and handle pattern, for this reason i hope it will go higher in medium-long term First target: 73 $ Second target: 90 $ Third target: 100 $
13.09.25 - 21:33
Biggybaer: buy Hims & Hers Health Inc. (Sharewise)
 
Kursziel: 506.0 €
07.09.25 - 02:24
HIMS Setting up AGAIN... (TradingView)
 
NYSE:HIMS - Dip Buy Box Wins Again! Second time bouncing off our $40-45 support. Breaking out of downtrend with a strong bullish candle. Target $67 then $73 ?
06.09.25 - 20:21
HIMS — Metrics-Led Swing Plan (4H/12H) (TradingView)
 
HIMS — Metrics-Led Swing Plan (4H/12H) Your constraints New entry (early momentum): manage risk at 44. “Best safety” entry: 28. Targets: 50 → 54 → 59 → 70 → 85. Investment window: now → July 2026.--- State 1 — What the Metric Table is Saying (and how to act) Liquidity & Participation Float / Vol·Float: ~0.12× currently → drift/early trend regime. Rules: 51” (promote TP2 path). “Price < 44” (momentum plan invalidated). “Vol·Float ≥ 0.2× / 0.3×” (permission to widen targets). “Close < 48.2 VWAP then failure retest” (reduce risk).--- Disclaimer (read me) This is educational and based on what's visible on your screenshots/metrics. Markets change; confirm levels on your chart and adapt sizing to your own risk tolerance. No financial advice. Always use a hard stop and pre-define risk before entry.
05.09.25 - 14:30
HIMS Bouncing Off Ascending Support (TradingView)
 
HIMS is bouncing off an ascending support, as well as the 200day SMA. It has rising volume with MACD crossing above signal line. Entering 48c 19Dec2025
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Wen Gott vernichten will, den verblendet er vorher. - Sophokles
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!